au.\*:("SANG KYOON KIM")
Results 1 to 24 of 24
Selection :
Nanoparticle delivery of a peptide targeting EGFR signalingSANG KYOON KIM; HUANG, Leaf.Journal of controlled release. 2012, Vol 157, Num 2, pp 279-286, issn 0168-3659, 8 p.Article
Glucosylated heparin derivatives as non-toxic anti-cancer drugsGEE YOUNG LEE; SANG KYOON KIM; BYUN, Youngro et al.Journal of controlled release. 2007, Vol 123, Num 1, pp 46-55, issn 0168-3659, 10 p.Article
A high-performance strategy for sensorless induction motor drive using variable link voltageYOUNG AHN KWON; SANG KYOON KIM.IEEE transactions on power electronics. 2007, Vol 22, Num 1, pp 329-332, issn 0885-8993, 4 p.Article
On-line Chinese character recognition using ART-based stroke classificationHANG JOON KIM; JONG WHA JUNG; SANG KYOON KIM et al.Pattern recognition letters. 1996, Vol 17, Num 12, pp 1311-1322, issn 0167-8655Article
Liphophilic complexation of heparin based on bile acid for oral deliveryDONG YUN LEE; LEE, Jisook; LEE, Seulki et al.Journal of controlled release. 2007, Vol 123, Num 1, pp 39-45, issn 0168-3659, 7 p.Article
Prevention effect of orally active heparin derivative on deep vein thrombosisSANG KYOON KIM; DONG YOON LEE; CHOONG YONG KIM et al.Thrombosis and haemostasis. 2006, Vol 96, Num 2, pp 149-153, issn 0340-6245, 5 p.Article
On-line recognition of Korean characters using ART neural network and hidden Markov modelSANG KYOON KIM; SE MYUNG PARK; JONG KOOK LEE et al.Journal of systems architecture. 1998, Vol 44, Num 12, pp 971-984, issn 1383-7621Article
On-line recognition of handwritten chinese characters based on hidden Markov modelsHANG JOON KIM; KYUNG HYUN KIM; SANG KYOON KIM et al.Pattern recognition. 1997, Vol 30, Num 9, pp 1489-1500, issn 0031-3203Article
Pharmacokinetics of a new, orally available ceftriaxone formulation in physical complexation with a cationic analogue of bile acid in ratsLEE, Seulki; SANG KYOON KIM; DONG YUN LEE et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 5, pp 1869-1871, issn 0066-4804, 3 p.Article
An HMM-based character recognition network using level buildingHANG JOON KIM; SANG KYOON KIM; KYUNG HYUN KIM et al.Pattern recognition. 1997, Vol 30, Num 3, pp 491-502, issn 0031-3203Article
Cationic analog of deoxycholate as an oral delivery carrier for ceftriaxoneLEE, Seulki; SANG KYOON KIM; DONG YUN LEE et al.Journal of pharmaceutical sciences. 2005, Vol 94, Num 11, pp 2541-2548, issn 0022-3549, 8 p.Article
A newly developed oral heparin derivative for deep vein thrombosis : Non-human primate studySANG KYOON KIM; DONG YUN LEE; CHOONG YONG KIM et al.Journal of controlled release. 2007, Vol 123, Num 2, pp 155-163, issn 0168-3659, 9 p.Article
Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulationSANG KYOON KIM; VAISHALI, Bagalkot; LEE, Eunhye et al.Thrombosis research. 2006, Vol 117, Num 4, pp 419-427, issn 0049-3848, 9 p.Article
Enhancing effect of chemically conjugated deoxycholic acid on permeability of calcitonin in Caco-2 cellsKIM, Sunhee; LEE, Hyunhee; LEE, Seulki et al.Drug development research. 2005, Vol 64, Num 2, pp 129-135, issn 0272-4391, 7 p.Article
Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulantSANG KYOON KIM; DONG YUN LEE; LEE, Eunhye et al.Journal of controlled release. 2007, Vol 120, Num 1-2, pp 4-10, issn 0168-3659, 7 p.Article
Pharmacokinetic evaluation of an oral tablet form of low-molecular-weight heparin and deoxycholic acid conjugate as a novel oral anticoagulantJIN WOO PARK; OK CHEOL JEON; SANG KYOON KIM et al.Thrombosis and haemostasis. 2011, Vol 105, Num 6, pp 1060-1071, issn 0340-6245, 12 p.Article
Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonanceSANG KYOON KIM; KIM, Kwangmeyung; LEE, Seulki et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 5, pp 861-870, issn 0731-7085, 10 p.Article
An extraction and segmentation of the picture and characters in Korean documentJONG-KOOK LEE; SANG-KYOON KIM; HANG-JOON KIM et al.Computers & industrial engineering. 1994, Vol 27, Num 1-4, pp 529-533, issn 0360-8352Conference Paper
Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugateDONG YUN LEE; SANG KYOON KIM; YOO SHIN KIM et al.Journal of controlled release. 2007, Vol 118, Num 3, pp 310-317, issn 0168-3659, 8 p.Article
High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivativesJIN WOO PARK; OK CHEOL JEON; SANG KYOON KIM et al.Journal of controlled release. 2010, Vol 148, Num 3, pp 317-326, issn 0168-3659, 10 p.Article
Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugatesSANG KYOON KIM; EUN HYE LEE; VAISHALI, Bagalkot et al.Journal of controlled release. 2005, Vol 105, Num 1-2, pp 32-42, issn 0168-3659, 11 p.Article
Antiangiogenic Activity of Orally Absorbable Heparin Derivative in Different Types of Cancer CellsDONG YUN LEE; SUNG WON LEE; SANG KYOON KIM et al.Pharmaceutical research. 2009, Vol 26, Num 12, pp 2667-2676, issn 0724-8741, 10 p.Article
Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeysLEE, Yong-Kyu; SANG KYOON KIM; DONG YUN LEE et al.Journal of controlled release. 2006, Vol 111, Num 3, pp 290-298, issn 0168-3659, 9 p.Article
Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitorLEE, Esak; KIM, Yoo-Shin; IN SAN KIM et al.International journal of cancer (Print). 2009, Vol 124, Num 12, pp 2755-2765, issn 0020-7136, 11 p.Article